|
|
TABLE 2.
Anti-SIV responses of treated and control
monkeysa
|
|
| Treatment |
Animal |
Absorbance at 405 nm at
wk postchallenge
|
No. of antibody-negative
animals/total |
| 2 |
4 |
8 |
12
|
|
| CAP:I |
89D420 |
0.182 |
0.221 |
0.169 |
0.034 |
3/6
|
|
H608 |
0.171 |
0.141 |
0.151 |
0.035
|
|
359L |
0.167 |
0.455 |
ND |
ND
|
|
407L |
0.157 |
0.156 |
0.160 |
0.043
|
|
H671 |
0.170 |
0.426 |
ND |
ND
|
|
89D367 |
0.170 |
0.304 |
ND |
ND
|
| CAP:II |
89C001 |
0.168 |
0.055 |
0.048 |
0.039 |
4/6
|
|
P778 |
0.181 |
0.089 |
0.013 |
0.035
|
|
976W |
0.188 |
0.236 |
1.913 |
1.486
|
|
P851 |
0.193 |
0.167 |
0.377 |
0.172
|
|
936P |
0.193 |
0.035 |
0.036 |
0.040
|
|
P407 |
0.158 |
0.066 |
0.087 |
0.053
|
| Control |
89D264 |
0.159 |
0.371 |
0.853 |
0.595 |
0/4
|
|
89D205 |
0.175 |
0.466 |
ND |
ND
|
|
59R |
0.156 |
0.495 |
1.069 |
0.347
|
|
AH37 |
0.159 |
0.452 |
0.765 |
0.467 |
|
|
a
Results in italics correspond to single
treatment and challenge. A whole-virus antigen ELISA was used to
evaluate seroconversion to SIV. The historical cutoff for this assay is
an optical density of 0.250. ND, not done. Positive responses are
indicated in bold.
|